Navigation Links
Lab-on-chip testing for 'bird flu' developed by Singapore scientists
Date:9/24/2007

SINGAPORE, Sept. 23, 2007 - Researchers at the Institute of Bioengineering and Nanotechnology (IBN), Institute of Molecular and Cell Biology (IMCB) and Genome Institute of Singapore (GIS) have successfully developed a miniaturized device that can be used to detect the highly pathogenic avian flu (H5N1) virus.

If successfully commercialized, this device could be deployed in affected regions for pre-emptive surveillance of nascent avian flu epidemic.

According to project leader and lead author of the Nature Medicine publication, IBN Research Scientist Dr Juergen Pipper, "With our device, medical or humanitarian aid workers would be able to detect the presence of the H5N1 virus directly from throat swab samples on-site in less than half an hour."

With early warning, a potential avian flu epidemic can be averted. Avian influenza is now entrenched in Asia, with sporadic human infections resulting from either direct contact with infected birds or limited human-to-human transmission. Globalization and seasonal avian migration patterns have resulted in the disease spreading rapidly to other parts of the world.

The device comprises a unique platform developed by IBN that uses magnetic force to manipulate individual droplets containing silica-coated magnetic particles.

"The novelty of our method lies in the way that the droplet itself becomes a pump, valve, mixer, solid-phase extractor and real-time thermocycler. Complex biochemical tasks can thus be processed in a fashion similar to that of a traditional biological laboratory on a miniature scale," explained Dr Pipper.

The all-in-one droplet-based device is superior to commercially available solutions as it integrates the entire workflow of viral RNA isolation, purification, preconcentration, and detection.

Tests have shown that IBN's platform is as sensitive as, and around 10 times faster than available tests, yet it could potentially be 40 to 100 times c
'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Page: 1 2

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
3. Diabetic testing gets easier
4. FDA changes rules on testing drugs for children
5. Gene testing kit specific for Doctors
6. Testing for blood sugar levels made easier
7. H.Pylori testing recommended in patients with peptic ulcer
8. DNA Testing For More Accurate Results
9. SARS vaccine shows promise in Animal Testing
10. Testing Of Saliva May Predict Dental Caries
11. Diagnosing Sleep Apnea By Overnight Sleep Testing Method

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... A team of Kendall Hunt authors earned the ...d at the recent National Association for Gifted Ch...ember 5-7, 2009. , Dubuqu...l Hunt authors earned the 2009 Gifted Child Quarte... Association for Gifted Children’s annual co...
(Date:12/2/2009)...TA, Dec. 2 In response to rising s... FamilyLife, a non-profit ministry dedicated to su... Weekend to Remember® marriage conference at...anta from Dec. 11 - 13 at the Grand Hyatt Atlanta ... Remember is a marriage getaway aimed at strength...
(Date:12/2/2009)...illion - 4 State Campaign Features Small Business ...esses and Would Kill Jobs ,, WASHINGTON, Dec. ...e jobs summit scheduled for Thursday, Keeping Smal... Liberty, today announced a new $1 million 4 state...of the current health care legislation on small bu...
(Date:12/2/2009)...S ANGELES, Dec. 2 At a ...Tourism ministerial delegates came together to out...equired to give it the necessary thrust. Organized...edicaltourismassociation.com , the high-powered co...iscussed the opportunities and requests for assist...
(Date:12/2/2009)..., KANSAS CITY, Mo., Dec. 2 Lock...omprehensive, practical view on proposed health re... (Logo: http://www.newscom.com/cgi-bin/prnh/20090...od, bad, and ugly in the legislation, according to...on Benefit Group,s Compliance Services Division ...
Breaking Medicine News(10 mins):Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2Health News:FamilyLife Supports Military Marriages in Atlanta 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 3Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 4Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3Health News:Lockton Outlines Implications of Proposed Health Reform Plans 2
... Students and Professors Honored for Their Researc... 12,outstanding Ph.D. students and two professors ...or research accomplishments in the field of organi...c,chemistry in pharmaceutical discovery. This year...
... 14 On Sunday, June 29,2008, West Coast Bank will... (ALAO) Reach the Bridge Run, Portland,s most uniq...choose their own start times, but must reach the,B...roads of Forest Park., West Coast Bank Relationsh...
...r of the International Association of Business Com...n of The University of Texas Medical School at Hou...prestigious award was given April 24 at the organi...nce in leadership , management, and communication ...
...heKnows.com,( http://www.SheKnows.com ), one of th...nnounced today the acquisition of PregnancyandBaby... online community for women from,preconception thr...offers a,comprehensive collection of articles, int...
...equired for Immediate Needs, NEW YORK, May 14 Tw...n a generation, news of its full impact on the,com...ickling in at a,painfully slow speed., According ...f villages and small towns were almost completely ...
...eadings rise, urges broader public action to curb ...ews) -- Just a few hours of exposure to particulat... and harm blood vessel function within 24 hours, a...roke, the researchers said. , Particulate matter (...
Other Medicine News:Health News:Roche Symposium Showcases Accomplishments of Next Generation of Chemists 2Health News:Roche Symposium Showcases Accomplishments of Next Generation of Chemists 3Health News:UT Houston Dean Colasurdo named Executive Communicator of the Year 2Health News:SheKnows Acquires PregnancyandBaby - Online Community From Preconception Through Birth 2Health News:UNICEF Rushing Medical Supplies, Tents, Clean Water to Children Affected by Powerful Earthquake in China 2Health News:Pollution Particles Impair Blood Vessel Function 2
(Date:12/1/2009)...RK, Dec. 1 Reportlinker.com announ... in its catalogue: ,, Medical Oxygen Systems ...reportlinker.com/p0164334/Medical-Oxygen-Systems--... medical oxygen systems market for home healthcare...s. The buoyant growth expectations stem from demog...
(Date:12/1/2009)...N.J., Dec. 1 Johnson & Johnson... announced today that it has submitted a New Drug ...stration (FDA) for tapentadol extended release (ER...he management of moderate to severe chronic pain i...c pain, defined as pain that persists for long per...
(Date:12/1/2009)...STATION, N.J., Dec. 1 Merck & ...rug Administration (FDA) has approved ZEGERID OTC(...apsules), for over-the-counter treatment of freque...he-counter by Schering-Plough HealthCare Products,...amp; Co., Inc. Schering-Plough and Merck merged on...
Breaking Medicine Technology:Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 2New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 3New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 4New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 5New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 7FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 2FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 3FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 4Interventional radiology resources cover peripheral arterial disease 56584 1Interventional radiology resources cover peripheral arterial disease 56584 2Interventional radiology resources cover peripheral arterial disease 56584 3Toward a nanomedicine for brain cancer 9839 1ACLA Opposes Proposed LabTax 56582 1ACLA Opposes Proposed LabTax 56582 2
... by Medical Research Council, LEXINGTON, Mass., A...EV ) announced today the completion of,enrollment ... PRO 2000, the,Company,s candidate vaginal microbi...transmitted infections. The trial is sponsored by ...) and conducted by the Microbicides,Development Pr...
...ciences, Inc. (Nasdaq: HGSI ) today announced tha...ng of patients in a randomized Phase 2 trial of,HG...therapy agents,paclitaxel and carboplatin as first...er (NSCLC)., (Logo: http://www.newscom.com/cgi-b...medical need for effective treatment options for,n...
Other Medicine Technology:Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: